(Q44112817)

English

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

scientific article published in July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Kazuko Sakai

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Atsushi Horiike

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Darryl L Irwin

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Keita Kudo

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yoshihiko Fujita

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Azusa Tanimoto

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Toshio Sakatani

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ryota Saito

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kyohei Kaburaki

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Noriko Yanagitani

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fumiyoshi Ohyanagi

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Makoto Nishio

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kazuto Nishio

13

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1198-1204

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

EGFR T790M mutation: a double role in lung cancer cell survival?

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12211

21 January 2018

Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23721103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23721103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CAS.12211

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44112817&oldid=2140006681"